WHO WE ARE
CellSpring is a biotech company dedicated to becoming the global leader in 3-dimensional cell culture. Our fully automated 3D Bloom® Biopolymer Platform enables more informed "stop/go" decisions for preclinical candidates. We offer contract services, partnering, and seamless lab integrations to help identify hits and avoid costly failures earlier in your research timeline.
Our focus is value creation. Our goal is to foster development of the next generation of great medicines.
Kramer Schmidt, MBA
Chris Millan, PhD
Co-Founder & CEO
Co-Founder & CTO
Kramer has worked in strategy and operations for the Hospital Corporation of America and DiaTech Oncology, a clinical laboratory company. He holds an MBA from Vanderbilt University.
Inventor of 3D Bloom, Chris holds an MSc and PhD from the ETH Zürich. He has conducted research at the MIT Langer Lab, Harvard, and Novartis Consumer Health.
Dr. Flurina Clement Frey,
Dr. med. vet., PhD
Miriam Zimmermann, PhD
Dr. Zimmermann earned a PhD from The Institute of Cancer Research (ICR) in the UK. She completed a PostDoc in the lab of Prof. Dr. Wilhelm Krek at the ETH Zürich.
After her studies and doctoral thesis in veterinary medicine at the University of Zurich, Flurina obtained her PhD in Cellular and Biomedical Sciences, University of Bern.
BOARD OF ADVISORS
Founder & CEO
Fmr. President & CEO
Hoffmann La-Roche North America
Novartis Venture Fund
Anja König, PhD
Mark Harris, PhD, MBA
Marcy Zenobi-Wong, PhD
"The best way to predict the future is to invent it.”
– Alan Kay
While there are no openings currently for employee
or student positions, we always accept resumes
from the best and the brightest. If you’re interested
in joining us, we would love to hear from you.
Email your resume to firstname.lastname@example.org.